The September incident at Cascadia of Boise involved Resident #36, who requires two units of Insulin Lispro injected under the skin before each meal to manage diabetes. Federal inspectors observed the nurse administering the medication without following manufacturer safety protocols.
On September 24 at 11:58 AM, RN #3 prepared the insulin pen by removing the old needle, sanitizing the tip, and attaching a new needle. She dialed the pen to the prescribed two units but failed to prime the device before injection.
When questioned, RN #1 defended the practice, stating she did not prime the needle "because it was an old pen." She claimed priming was only necessary for new pens.
The facility's Acting Director of Nursing contradicted this explanation hours later. At 4:45 PM that same day, the administrator confirmed that insulin pens should be primed before each administration, regardless of whether they are new or previously used.
Manufacturer guidelines support the director's position. The Insulin Lispro website, accessed by inspectors on September 29, explicitly states that priming removes air from the needle and cartridge that accumulates during normal use. The process ensures the pen functions correctly for accurate dosing.
"If you do not prime before each injection, you may get too much or too little insulin," the manufacturer warns.
For diabetic patients like Resident #36, receiving incorrect insulin doses creates immediate health risks. Too little insulin allows blood sugar to spike dangerously high, potentially leading to diabetic ketoacidosis, a life-threatening condition requiring emergency hospitalization. Too much insulin drives blood sugar dangerously low, causing confusion, seizures, or loss of consciousness.
The resident had been admitted to Cascadia of Boise earlier this year and readmitted on an undisclosed date with multiple medical conditions including diabetes. A physician's order dated September 2 specified the exact insulin protocol that nurses failed to follow properly.
Federal inspectors determined the medication error violated professional standards of practice for nursing facilities. The citation noted that while only one resident was directly affected by the observed violation, the improper technique suggested systemic problems with insulin administration training or oversight.
The inspection was conducted in response to a complaint, though the specific nature of the complaint was not disclosed in federal records. Inspectors observed medication administration for two residents but found violations affecting Resident #36's care.
Insulin administration errors rank among the most dangerous medication mistakes in nursing homes because of the drug's narrow therapeutic window and immediate physiological effects. Unlike many medications where small dosing errors may go unnoticed, insulin mistakes often produce rapid, observable symptoms that can escalate to medical emergencies within hours.
The violation occurred despite clear manufacturer instructions and facility policies requiring proper priming procedures. The disconnect between the nurse's explanation and the administrator's later clarification suggests inadequate staff training or inconsistent enforcement of safety protocols.
Cascadia of Boise must now develop a plan of correction addressing the insulin administration failures and demonstrate compliance with professional medication standards. The facility has not publicly disclosed whether additional staff training or policy changes resulted from the inspection findings.
Resident #36 continues to require insulin injections before each meal, making proper administration technique critical for ongoing diabetes management and prevention of potentially life-threatening blood sugar fluctuations.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Cascadia of Boise from 2025-11-19 including all violations, facility responses, and corrective action plans.